Clinical Trials
8
Active:0
Completed:8
Trial Phases
3 Phases
Phase 1:1
Phase 2:3
Phase 3:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
Phase 3
4 (50.0%)Phase 2
3 (37.5%)Phase 1
1 (12.5%)A Study to Assess the Safety of ASP7374 in Adult Subjects Aged 20 or Older
Phase 3
Completed
- Conditions
- VaccineInfluenza
- First Posted Date
- 2015-02-19
- Last Posted Date
- 2017-09-29
- Lead Sponsor
- UMN Pharma Inc.
- Target Recruit Count
- 55
- Registration Number
- NCT02366962
Study of ASP7374, Cell-culture-derived Influenza Vaccine
Phase 3
Completed
- Conditions
- InfluenzaVaccine
- First Posted Date
- 2013-10-14
- Last Posted Date
- 2017-09-29
- Lead Sponsor
- UMN Pharma Inc.
- Target Recruit Count
- 900
- Registration Number
- NCT01961947
A Study to Evaluate Intramuscular ASP7374
Phase 3
Completed
- Conditions
- VaccineInfluenza
- First Posted Date
- 2013-10-14
- Last Posted Date
- 2017-09-29
- Lead Sponsor
- UMN Pharma Inc.
- Target Recruit Count
- 55
- Registration Number
- NCT01961960
Phase-3 Study of ASP7374, Cell-culture-derived Influenza Vaccine
Phase 3
Completed
- Conditions
- Influenza
- First Posted Date
- 2013-01-15
- Last Posted Date
- 2017-09-29
- Lead Sponsor
- UMN Pharma Inc.
- Target Recruit Count
- 1020
- Registration Number
- NCT01767896
A Study to Evaluate the Immune Response to the ASP7373 and Its Safety in Healthy Adult Volunteers
Phase 2
Completed
- Conditions
- Healthy
- First Posted Date
- 2011-10-12
- Last Posted Date
- 2017-09-29
- Lead Sponsor
- UMN Pharma Inc.
- Target Recruit Count
- 180
- Registration Number
- NCT01450579
- Prev
- 1
- 2
- Next
News
No news found